Laboratory and clinical management of the highly sensitized organ transplant recipient

Human Immunology

Volumn 26, Issue 4, 1989, Pages 245-260

  Braun, William E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIBODY;

ADULT; B LYMPHOCYTE; BIOLOGICAL MODEL; CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SEROLOGY;

AUTOANTIBODIES; B-LYMPHOCYTES; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0024388749     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(89)90003-7     Document Type: Article

References (56)

1. Basic microlymphocytotoxicity technique
2. Modifications of the microcytotoxicity test
3. Detection of alloantibodies using a sensitive antiglobulin microtoxicity test: Identification of low levels of performed antibody in accelerated allograft rejection
4. A comparison of the antiglobulin versus extended incubation time crossmatch results in 223 renal transplants
5. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation
6. Cytotoxins in disease; autocytotoxins in lupus
7. Importance of the autocontrol crossmatch in human renal transplantation
8. Positive B cell crossmatches: Specificity of antibody and graft outcome
9. Successful transplantation with a positive T- and B-cell crossmatch due to autoreactive antibodies
10. Characterization of cytotoxic antibody
11. Anti-idiotypic antibodies and the relevance to transplantation
12. Successful kidney transplant in patient with positive crossmatch due to autoantibodies
13. Autolymphocytotoxins in cardiac transplantation: Serology, significance, and association with HLA-A1 and A3
14. Kidney transplant recipients with long incubation-positive, antiglobulin-negative T-cell cross-matches
15. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches
16. Cold-reactive alloantibodies and allograft malfunction occurring immediately post-transplant
17. Cold-reacting IgM antibody-induced renal allograft failure
18. B cell crossmatch in renal transplantation
19. Significance of HLA-D/DR matching in renal transplantation
20. A new strategy to improve kidney graft survival: The induction of CML nonresponsiveness
21. Immediate rejection of HLA-A, B compatible HLA-DR incompatible kidney with a positive donor-recipient B cell crossmatch
22. Renal allograft rejection associated with presensitization to HLA-DR antigens
23. Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies
24. B cell antibodies and crossmatching
25. Positive B cell crossmatches in highly sensitized patients—influence of antibody specificity on renal transplant outcome
26. Positive B lymphocyte crossmatch and glomerular rejection in renal transplant recipients
27. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches
28. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches
29. Outcome of renal transplantation following a positive crossmatch with historical sera: The second analysis of the ASHI survey
30. Preformed IgG and IgM antibodies in transplant patients
31. Improved survival and function of renal transplants with positive B-cell crossmatches
32. Long-term cadaver allograft survival in the recipient with a positive B lymphocyte crossmatch
33. Donor-specific B and T lymphocyte antibodies and kidney graft survival
34. Lymphocyte alteration by procainamide: Relation to drug-induced lupus erythematosus syndrome
35. Hyddralyze-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility
36. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: Studoes in patients with dermaitis herpetiforms and normal subject
37. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the poseseion of HLA-B8/DR3
38. Hyperracute rrejection of a renal allgraft in the presence of anti-HLA-Cw5 antibody
39. Srceening sera for HLA antibodies
40. The vascular endothelial cell-specific antigen system: THree year's experience in monocyte crossmatching
41. Antibody characterization in the reference facility
42. Calculation of a predictive value for transplantation
43. HLA matching effects
44. Molecular, genetic, and clinical aspects of the HLA system
45. The effect of first cadaver renal transplant HLA-A,B match on sensititation levels and retransplant rates following graft failure
46. A controlled evaluating intensive plasma exchange in renal transplantation
47. Renal transplantation after removal and prevention of re-synthesis of HLA antibodies
48. extracorporeal removal of HLA antibodies (HLA-Ab) in dialysis patients by immunosoerption
49. Removal of anti-HLA antibodies prior to transplantation: An effective successful stradegy for highly sensitized renal allograft recipients
50. Transfusions and cadaver kidney transplant: The CTS data
51. Correction of the anemia hemodialysis (HD) patients with recombinant human erythropoietin (rHuEpo): Result of a multicenter study
52. The Impact of recombinant erythropoietin (Epo) on pre-transplant recipient sensitization and tranplant outcome